drugset / Trial / NCT02140450

Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection

NCT02140450

RandomizedParallel-groupTriple-blindPrevention

Summary

To assess the effect of prophylactic antiglaucoma agents in prevention of acute intraocular pressure rise after intravitreal injection.

Timeline

Start
2012-02
Primary completion
2014-01
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetazolamide Small molecule 250 mg Oral
Comparator Brimonidine Small molecule 2 unknown Topical
Comparator Mannitol Diagnostic / imaging agent 1.5 g/kg Intravenous
Comparator Timolol Other / unclassified 2 unknown Topical

Indications

No indication recorded.